Live feed
Filing
SC 13G/A
SC 13G/A0001104659-23-017128·Travere Therapeutics, Inc.
Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
Security class unavailable · CUSIP: 89422G107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,515,446
- Percent of class
- 5.4800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-017128
- Form type
- SC 13G/A
- Filer
- Travere Therapeutics, Inc.
- CIK
- CIK 1438533
- Filed
- Feb 09, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership